HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ekaterina Laukhtina Selected Research

Globulins

3/2022Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approach.
1/2022A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
10/2021Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer.
9/2021Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer.
9/2021Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy.
7/2021Prognostic value of the preoperative albumin-globulin ratio in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration.
2/2021Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma.
1/2021Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ekaterina Laukhtina Research Topics

Disease

32Neoplasms (Cancer)
09/2022 - 01/2020
29Carcinoma (Carcinomatosis)
08/2022 - 06/2020
23Urinary Bladder Neoplasms (Bladder Cancer)
11/2022 - 01/2020
21Prostatic Neoplasms (Prostate Cancer)
06/2022 - 11/2020
11Non-Muscle Invasive Bladder Neoplasms
08/2022 - 10/2020
8Renal Cell Carcinoma (Grawitz Tumor)
07/2022 - 12/2020
7Inflammation (Inflammations)
06/2022 - 09/2021
6Lymphatic Metastasis
08/2022 - 11/2021
6Neoplasm Metastasis (Metastasis)
03/2022 - 06/2020
4Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2021 - 10/2018
3Disease Progression
09/2022 - 01/2021
2Urinary Incontinence
01/2022 - 01/2020
2Overactive Urinary Bladder (Overactive Bladder)
01/2022 - 09/2021
2Febrile Neutropenia
01/2021 - 01/2021
2Anemia
01/2021 - 01/2021
2Fatigue
01/2021 - 01/2021
1Sepsis (Septicemia)
10/2022
1Carcinoma in Situ
09/2022
1Urologic Neoplasms (Urological Cancer)
05/2022
1Residual Neoplasm
04/2022
1Injection Site Reaction
01/2022
1Kidney Neoplasms (Kidney Cancer)
01/2022
1Erectile Dysfunction
04/2021
1Constipation
01/2021
1Dementia (Dementias)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Infections
01/2021
1Alopecia (Baldness)
01/2021

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
08/2022 - 01/2021
8GlobulinsIBA
03/2022 - 01/2021
7Immune Checkpoint InhibitorsIBA
07/2022 - 01/2020
7AlbuminsIBA
03/2022 - 01/2021
5AndrogensIBA
01/2022 - 01/2021
5Serum AlbuminIBA
10/2021 - 01/2021
4Androgen Receptors (Androgen Receptor)IBA
06/2022 - 11/2020
3pembrolizumabIBA
01/2022 - 01/2022
3Tyrosine Kinase InhibitorsIBA
01/2022 - 10/2021
2PlatinumIBA
03/2022 - 01/2021
2Hormones (Hormone)IBA
01/2022 - 01/2021
2GemcitabineFDA Link
01/2022 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2021
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2021
2Docetaxel (Taxotere)FDA Link
01/2022 - 01/2021
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2021 - 01/2021
2Alanine Transaminase (SGPT)IBA
06/2021 - 12/2020
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2021 - 12/2020
2Prostate-Specific Antigen (Semenogelase)IBA
11/2020 - 12/2019
2ThuliumIBA
12/2018 - 10/2018
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2022
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2022
1DNA (Deoxyribonucleic Acid)IBA
05/2022
1Carboplatin (JM8)FDA LinkGeneric
03/2022
1isopropyl cyanoacrylateIBA
02/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1atezolizumabIBA
01/2022
1NivolumabIBA
01/2022
1EndoglinIBA
01/2022
1Solifenacin SuccinateFDA Link
01/2022
1AntigensIBA
01/2022
1fesoterodineFDA Link
01/2022
1acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamideFDA Link
01/2022
1imidafenacinIBA
01/2022
1N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1C-Reactive ProteinIBA
01/2022
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2022
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2022
1oxybutynin (Tavor)FDA LinkGeneric
01/2022
1Carrier Proteins (Binding Protein)IBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1relugolixIBA
01/2022
1Histone MethyltransferasesIBA
11/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
03/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021

Therapy/Procedure

21Therapeutics
09/2022 - 01/2020
20Cystectomy
09/2022 - 01/2021
11Drug Therapy (Chemotherapy)
07/2022 - 01/2021
10Immunotherapy
05/2022 - 10/2020
10Prostatectomy (Retropubic Prostatectomy)
01/2022 - 11/2020
9Transurethral Resection of Bladder
10/2022 - 10/2020
8Nephroureterectomy
03/2022 - 01/2021
7Neoadjuvant Therapy
07/2022 - 01/2021
6Nephrectomy
07/2022 - 12/2020
4Castration
06/2022 - 11/2020
4Radiotherapy
03/2022 - 01/2021
3Transurethral Resection of Prostate (TURP)
01/2021 - 10/2018
2Combination Drug Therapy (Combination Chemotherapy)
03/2022 - 01/2021
2Adjuvant Chemotherapy
01/2022 - 06/2020
2Solid-State Lasers
10/2020 - 12/2018
2Lasers (Laser)
12/2018 - 10/2018
1Antibiotic Prophylaxis
10/2022
1Conservative Treatment
09/2022
1Urinary Diversion (Ileal Conduit)
07/2022
1Brachytherapy
01/2022
1Cryosurgery
01/2022
1Radiofrequency Ablation
01/2022
1Lymph Node Excision (Lymph Node Dissection)
01/2021
1Overlapping Surgery
01/2021
1Duration of Therapy
01/2021